The Food and Drug Administration approved for sale a significant advance toward a so-called artificial pancreas for Type 1 diabetes patients, a long-awaited insulin pump that aims to take some of the guesswork out of blood-sugar control. The product from Medtronic PLC, called the MiniMed 670G, combines two devices that attach to the outside of the body—a pump that delivers insulin through a tiny tube inserted under the skin, and a...

Source: Wall Street Journal September 28, 2016 20:13 UTC